Quest Partners LLC Has $325,000 Stock Holdings in OrthoPediatrics Corp. (NASDAQ:KIDS)

Quest Partners LLC boosted its holdings in shares of OrthoPediatrics Corp. (NASDAQ:KIDS) by 924.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,986 shares of the company’s stock after purchasing an additional 10,816 shares during the period. Quest Partners LLC’s holdings in OrthoPediatrics were worth $325,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its stake in OrthoPediatrics by 1.3% during the first quarter. Vanguard Group Inc. now owns 883,827 shares of the company’s stock worth $25,772,000 after purchasing an additional 11,100 shares during the period. Harbor Capital Advisors Inc. lifted its stake in OrthoPediatrics by 268.1% during the third quarter. Harbor Capital Advisors Inc. now owns 246,860 shares of the company’s stock worth $6,692,000 after purchasing an additional 179,803 shares during the period. Paradigm Capital Management Inc. NY lifted its stake in OrthoPediatrics by 8.0% during the second quarter. Paradigm Capital Management Inc. NY now owns 134,400 shares of the company’s stock worth $3,865,000 after purchasing an additional 10,000 shares during the period. Mutual of America Capital Management LLC lifted its stake in OrthoPediatrics by 195.1% during the third quarter. Mutual of America Capital Management LLC now owns 107,609 shares of the company’s stock worth $2,917,000 after purchasing an additional 71,146 shares during the period. Finally, Kennedy Capital Management LLC bought a new position in OrthoPediatrics during the first quarter worth about $2,894,000. Institutional investors own 69.05% of the company’s stock.

OrthoPediatrics Stock Performance

NASDAQ:KIDS opened at $26.61 on Tuesday. OrthoPediatrics Corp. has a 1 year low of $22.41 and a 1 year high of $36.23. The firm has a 50 day moving average of $26.45 and a 200-day moving average of $29.29. The company has a current ratio of 7.17, a quick ratio of 3.68 and a debt-to-equity ratio of 0.19. The stock has a market capitalization of $644.49 million, a P/E ratio of -21.63 and a beta of 1.16.

Wall Street Analyst Weigh In

KIDS has been the subject of a number of analyst reports. Needham & Company LLC restated a “buy” rating and set a $42.00 price target on shares of OrthoPediatrics in a research note on Friday, November 8th. Truist Financial cut their target price on shares of OrthoPediatrics from $34.00 to $28.00 and set a “hold” rating for the company in a research note on Monday, October 14th. Finally, JMP Securities reiterated a “market outperform” rating and issued a $50.00 target price on shares of OrthoPediatrics in a research note on Friday, September 13th.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.